Enabling next-generation integrated drug delivery, today.

At the juncture of efficacy, safety and pharmacoeconomics lies Pharma 3.0. Today’s pharmaceutical companies who integrate a cost-effective compliance tracking mechanism into their therapies are gaining an enormous competitive advantage. These service-enabled drug solutions are powering new levels of personalization, adherence and real-world outcomes.


Connected devices fueling growth in Remote Patient Monitoring
44
%
Annual Increase in patients monitored remotely (2017) 1
Nonadherence leading cause of hospitalization
10
%
Hospitalizations in older adults caused by medication nonadherence 2,3
Physical activity equates to healthcare savings
39
%
Reduction in mean annual health care expenditure by walking 30 minutes, 5 times a week 4

Home + On the Go

Our wireless, miniaturized reference designs and medical-grade connectivity platforms enable rapid deployment of integrated drug delivery solutions to track and guide compliant patient therapy.

Learn More

Insights & Events

Catch up on the latest from Capsule

11 FEB 2019

Francisco Partners Acquires Qualcomm Life

Francisco Partners, a leading technology-focused private equity firm, has announced it has acquired Qualcomm Life, Inc. a wholly owned subsidiary of Qualcomm Incorporated that offers end-to-end medical device connectivity across the continuum of care.

30 JAN 2019

Vitals Plus: Flexible, clinical-friendly workflow

An all-in-one solution for monitoring and clinical documentation that combines ease of use and efficiency.

1
mHealth and Home Monitoring, Berg Insight, 2017.
2
Iuga AO, McGuire MJ. Adherence and health care costs. Risk Management and Healthcare Policy. 2014;7:35-44. doi: 10.2147/RMHP.S19801.
3
AHRQ. Statistical Brief #225. Trends in Hospital Inpatient Stays in the United States, 2005 – 2014. June 2017.
4
J Am Heart Assoc. 2016;5: e003614 doi: 10.1161/ JAHA.116.003614.